European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology.,European Journal of Preventive Cardiology

当前位置： X-MOL 学术 › Eur. Assoc. Prev. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology.
European Journal of Preventive Cardiology ( IF 8.4 ) Pub Date : 2022-05-25 , DOI: 10.1093/eurjpc/zwab160
Suleman Aktaa _{1,

2,

3} , Baris Gencer _{4,

5} , Elena Arbelo _{6,

7,

8} , Constantinos H Davos ₉ , Ileana Désormais ₁₀ , Monika Hollander ₁₁ , Ana Abreu ₁₂ , Marco Ambrosetti ₁₃ , Maria Bäck _{14,

15} , David Carballo ₁₆ , Carolyn Crawford ₁₇ , Christi Deaton ₁₈ , Paul Dendale ₁₉ , Thijs M H Eijsvogels ₂₀ , Mary Galbraith ₁₇ , Massimo Francesco Piepoli ₂₁ , Annett Salzwedel ₂₂ , Yvo Smulders ₂₃ , Matthias Wilhelm ₂₄ , Giuseppe Biondi-Zoccai _{25,

26} , François Mach ₄ , Frank L J Visseren ₂₇ , Chris P Gale _{1,

2,

3}

Affiliation

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9LU, UK.
Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9LU, UK.
Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Division of Cardiology, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Cardiovascular Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Department of Thoracic and Cardiovascular Surgery and Angiology, Dupuytren University Hospital, Limoges, France.
Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, Utrecht 3584 CG, The Netherlands.
Cardiology Department, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, (CHULN) Lisboa, Lisbon, Portugal.
Cardiovascular Rehabilitation Unit, ASST Crema, Rivolta D'Adda Hospital, Rivolta D' Adda, Italy.
Unit of Physiotherapy, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Cardiology, Cardiovascular Center, University Hospital Geneva, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland.
ESC Patient Forum, Sophia Antipolis, France.
Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Forvie Site, Cambridge Biomedical Campus, Cambridge CB22 5DT, UK.
Heart Centre Hasselt and Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Heart Failure Unit, Cardiology, Guglielmo da Saliceto Hospital, and University pof Parma, Piacenza, Italy.
Department of Rehabilitation Medicine, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.
Department of Internal Medicine and Geriatrics, Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands.
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
Mediterranea Cardiocentro, Napoli, Italy.
Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Utrecht, The Netherlands.

AIMS To develop a set of quality indicators (QIs) for the evaluation of the care and outcomes for atherosclerotic cardiovascular disease (ASCVD) prevention. METHODS AND RESULTS The Quality Indicator Committee of the European Society of Cardiology (ESC) formed the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with Task Force members of the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice and the European Association of Preventive Cardiology (EAPC). We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care for ASCVD prevention by constructing a conceptual framework of care, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. In total, 17 main and 14 secondary QIs were selected across six domains of care for ASCVD prevention: (i) structural framework, (ii) risk assessment, (iii) care for people at risk for ASCVD, (iv) care for patients with established ASCVD, (v) patient education and experience, and (vi) outcomes. CONCLUSION We present the 2021 ESC QIs for Cardiovascular Disease Prevention, which have been co-constructed with EAPC using the ESC methodology for QI development. These indicators are supported by evidence from the literature, underpinned by expert consensus and aligned with the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice to offer a mechanism for the evaluation of ASCVD prevention care and outcomes.

中文翻译：

欧洲心脏病学会心血管疾病预防质量指标：由心血管疾病预防质量指标工作组与欧洲心脏病学会欧洲预防心脏病学协会合作制定。

目的制定一套质量指标 (QI)，用于评估动脉粥样硬化性心血管疾病 (ASCVD) 预防的护理和结果。方法和结果欧洲心脏病学会 (ESC) 质量指标委员会与 2021 年 ESC 临床实践心血管疾病预防指南工作组成员以及欧洲预防协会合作成立了心血管疾病预防质量指标工作组心脏病学（EAPC）。我们遵循 ESC QI 开发方法，其中包括 (i) 通过构建护理概念框架来确定 ASCVD 预防护理的关键领域，(ii) 通过对文献进行系统回顾来开发候选 QI， (iii) 使用改进的德尔菲法选择最终的 QI 集，以及 (iv) 评估所制定的 QI 的可行性。总共，在 ASCVD 预防的六个护理领域中选择了 17 个主要质量指标和 14 个次要质量指标：(i) 结构框架，(ii) 风险评估，(iii) 对 ASCVD 风险人群的护理，(iv) 对患有 ASCVD 的患者的护理建立 ASCVD，(v) 患者教育和经验，以及 (vi) 结果。结论我们提出了 2021 年心血管疾病预防 ESC QI，该 QI 是与 EAPC 使用 ESC QI 开发方法共同构建的。这些指标得到文献证据的支持，以专家共识为基础，并与 2021 年 ESC 临床实践心血管疾病预防指南保持一致，为评估 ASCVD 预防护理和结果提供机制。

更新日期：2021-10-23

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11